News | March 10, 2009

Abbott Launches VOYAGER NC Coronary Balloon Catheter

March 10, 2009 - Abbott today launched the VOYAGER NC Coronary Dilatation Catheter, a next-generation balloon dilatation catheter with high-pressure capability designed to optimize the treatment of patients with coronary artery disease (CAD) during angioplasty procedures.

VOYAGER NC is now available in the U.S., Europe and select countries in Asia and Latin America.

The new VOYAGER NC system can be used for both pre-dilatation and post-dilatation procedures. Physicians can use VOYAGER NC to navigate tortuous anatomy and open up lesions before a stent is delivered, or expand a stent more precisely against the vessel wall after it is implanted.

The VOYAGER NC is available in a wide variety of diameters (from 2 mm to 5 mm) and lengths (from 6 mm to 25 mm) on a rapid exchange delivery system.

"When choosing a dilatation catheter, one of the key attributes interventional cardiologists look for is the ability to accurately deliver the balloon to the target lesion, particularly in challenging coronary anatomy," said Dean J. Kereiakes, M.D., medical director, The Christ Hospital Heart and Vascular Center in Cincinnati, OH. "VOYAGER NC delivers on its promise as a high performance balloon dilatation catheter with high-pressure capability, frequently making difficult cases easier, even when treating the most challenging lesions."

Proprietary technological advancements that Abbott engineered into the VOYAGER NC balloon dilatation catheter include:

• A specialized tip with a smooth, rounded shape designed to deflect off stent struts and enhance balloon delivery through stents.

• Flexible tungsten markers designed to help physicians navigate through arteries and properly position the balloon within a treatment area.

• Bi-layer balloon material designed to make the balloon thinner and more flexible, enabling controlled balloon growth.

For more information: www.abbott.com

Related Content

Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init